Dann EJ. Response to Comment on: “Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?”. haematol [Internet]. 2026Sep.1 [cited 2026Sep.29];111(9):3181. Available from: https://haematologica.org/article/view/14215